Polyclonal Antibody to Preferentially Expressed Antigen In Melanoma (PRAME)

• Product Name Alternative:

  MAPE; OIP4; CT130; Cancer/Testis Antigen 130; Opa-interacting protein 4; Melanoma antigen preferentially expressed in tumors

• Synonyms:

  Preferentially Expressed Antigen In Melanoma

• Host:

  Rabbit

• Reactivity:

  Ra

• Immunogen:

  RPH323Hu02-Recombinant Preferentially Expressed Antigen In Melanoma (PRAME)

• Source:

  Polyclonal antibody preparation

• Applications:

  WB; IHC; ICC; IP.

• Field of Research:

  Tumor immunity

• Buffer:

  PBS, pH7.4, containing 0.02% NaN3,50% glycerol.

• Recommended Usage:

  Western blotting: 0.01-2µg/mL; < br/> Immunohistochemistry: 5-20µg/mL; < br/> Immunocytochemistry: 5-20µg/mL; < br/> Optimal working dilutions must be determined by end user.

• Organism Species:

  Homo sapiens (Human)

• CAS Number:

  9007-83-4